P res. Donald Trump says Americans could soon pay far less for GLP-1 medications used for diabetes, obesity, and heart ...

The benefit leaders emphasized that GLP-1s are just one part of the equation in addressing weight loss. Programs such as ...

Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...

Andy Richter got real about his Dancing With the Stars weight loss, attributing part of his slimdown to taking GLP-1 ...

After dropping so-so early-stage results on its dual GLP-1/GLP-2 agonist earlier this year, fierce competition in the obesity ...

Brooks Nader has kept it candid when it comes to her use of weight-loss drugs. The Sports Illustrated Swimsuit model has been ...

Weight loss at the time of GLP-1 discontinuation was 10.1% overall, 9.7% for those with T2D, and 11.1% for those without.

Truist pointed to updated GLP-1 intake features, including Klarna financing, shorter shipping intervals and new semaglutide ...

Pfizer seals the deal with Metsera for $10 billion after Novo Nordisk bowed out; President Donald Trump welcomes executives from Novo and Eli Lilly to the White House to announce that the companies’ ...

ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of ...